Great Lakes Advisors LLC Buys New Shares in DaVita Inc. $DVA

Great Lakes Advisors LLC purchased a new position in shares of DaVita Inc. (NYSE:DVA) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 8,588 shares of the company’s stock, valued at approximately $1,911,000.

A number of other large investors also recently modified their holdings of DVA. Fifth Third Bancorp raised its holdings in DaVita by 831.4% during the 1st quarter. Fifth Third Bancorp now owns 38,411 shares of the company’s stock valued at $5,903,000 after buying an additional 34,287 shares during the last quarter. Assenagon Asset Management S.A. grew its holdings in DaVita by 30.5% in the 2nd quarter. Assenagon Asset Management S.A. now owns 44,783 shares of the company’s stock worth $9,963,000 after acquiring an additional 10,477 shares during the last quarter. SG Americas Securities LLC increased its position in shares of DaVita by 27.4% in the first quarter. SG Americas Securities LLC now owns 212,293 shares of the company’s stock valued at $32,627,000 after acquiring an additional 45,609 shares during the period. LSV Asset Management raised its stake in shares of DaVita by 1.1% during the fourth quarter. LSV Asset Management now owns 936,768 shares of the company’s stock valued at $106,426,000 after acquiring an additional 9,739 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S raised its stake in shares of DaVita by 63.5% during the fourth quarter. BI Asset Management Fondsmaeglerselskab A S now owns 86,000 shares of the company’s stock valued at $9,770,000 after acquiring an additional 33,394 shares during the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

DVA has been the topic of several recent analyst reports. Truist Financial cut their target price on DaVita from $250.00 to $215.00 and set a “hold” rating on the stock in a research note on Friday, August 7th. TD Cowen upgraded DaVita from a “hold” rating to a “buy” rating and increased their price objective for the stock from $201.00 to $220.00 in a report on Friday, August 7th. Raymond James Financial set a $220.00 target price on DaVita in a research note on Friday, August 7th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $265.00 target price on shares of DaVita in a report on Wednesday, August 5th. Finally, Oppenheimer set a $220.00 price target on shares of DaVita in a report on Friday, August 7th. Four investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $221.75.

Insider Buying and Selling at DaVita

In other news, insider Kathleen Alyce Waters sold 15,405 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $208.40, for a total value of $3,210,402.00. Following the sale, the insider directly owned 109,194 shares of the company’s stock, valued at $22,756,029.60. The trade was a 12.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 1.90% of the company’s stock.

DaVita Stock Down 0.6%

NYSE DVA opened at $174.21 on Friday. The firm has a market capitalization of $11.11 billion, a PE ratio of 14.26, a P/E/G ratio of 0.58 and a beta of 0.88. The stock’s 50 day moving average is $214.96 and its 200 day moving average is $181.53. DaVita Inc. has a twelve month low of $101.00 and a twelve month high of $247.49.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $4.02 EPS for the quarter, beating the consensus estimate of $3.88 by $0.14. The business had revenue of $3.55 billion during the quarter, compared to analyst estimates of $3.50 billion. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.The company’s revenue for the quarter was up 5.2% on a year-over-year basis. During the same quarter last year, the firm posted $2.95 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. On average, research analysts anticipate that DaVita Inc. will post 14.57 earnings per share for the current year.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.